Torrent Pharma recalls over 8 lakh bottles of hypertension drug from US, Puerto Rico

PTI New Delhi | Updated on May 12, 2019 Published on May 12, 2019

Drug firm Torrent Pharma Inc is recalling over 8.82 lakh bottles of Losartan Potassium tablets, used for treatment of hypertension, from the US and Puerto Rico markets on account of deviations from the current good manufacturing norms, according to a report of the US health regulator.

The US-based arm of Torrent Pharmaceuticals is recalling 28,464 bottles of Losartan Potassium tablets USP in the strength of 25 mg manufactured by the parent company at its Indrad facility in Mehsana district, the latest Enforcement Report of the the United States Food and Drug Administration (USFDA) said.

All the ongoing voluntary recalls of the hypertension treatment drug are class II recalls, it added.

The reason for the recalls is “CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million”, the report said.

CGMP refers to the Current Good Manufacturing Practice regulations enforced by the USFDA.

As per the USFDA, a class II recall is initiated in a situation “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 12, 2019
This article is closed for comments.
Please Email the Editor